Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $47

Benzinga Newsdesk www.benzinga.com Negative 88.8%

Neg 88.8% Neu 0% Pos 0%

Morgan Stanley analyst Ryan Kenny maintains Lazard (NYSE:LAZ) with a Underweight and lowers the price target from $53 to $47.